Navigation Links
Patent Awarded for Miniature Chemical Detection Device
Date:3/11/2008

GOLDEN, Colo., March 11 /PRNewswire/ -- The U.S. Patent Office has awarded Dr. George Radziszewski a U.S. Patent (No. 7,342,664) for his revolutionary ChemiD Mini Lab, a miniature device that will identify chemical compounds on demand.

The ChemiD Mini Lab is designed to meet the critical need for an inexpensive, miniaturized analytical tool capable of rapidly and accurately detecting, identifying and monitoring the concentration of chemical substances.

The ChemiD Mini Lab is a novel configuration of a Fourier Transform Infrared (FTIR) spectrometer for spectrochemical analysis. FTIR is an instrument that can detect and decipher the molecular "fingerprint" of any chemical compound. Current FTIR technology is large, cumbersome and expensive.

"The ongoing hostilities in the Middle East and threats to homeland security underscore the need for an improved means of identifying explosives and toxic chemicals, so the market for such a device is enormous," according to Dr. Radziszewski, founder and CEO of ChemiD Research, LLC. He goes on to state, "our device could also contribute to improvements in energy efficiency, indoor/outdoor air quality and heighten the safety and security in millions of buildings worldwide." Similarly, the medical community "will benefit from a greatly enhanced potential for conducting non-invasive blood and bodily fluids sampling."

"Imagine every first responder and combat soldier with a handheld, chemical-detecting portable and automatic lab costing less than $500!" says Dr. Radziszewski. The patent culminates years of extensive research. The ChemiD Mini Lab will be the smallest, least expensive and most powerful device yet to be introduced. Capable of real-time detection and identification of explosives, chemicals, narcotics and other airborne contaminants, Dr. Radziszewski's patent is on its way to a huge commercial success!

Prototype testing will take several months followed by the development of commercial packaging before units will be available.

With his device, Dr. Radziszewski envisions contribution to an improved quality of life, as consumers are able to determine potentially hazardous chemicals in their food and environment or perform non-invasive blood lab work as easily as they use a watch to tell time or read a thermometer to determine the temperature.

ChemiD Research is a Limited Liability Company formed in 2004 in the State of Colorado. (http://www.chemid.com)

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=74463


'/>"/>
SOURCE ChemiD Research, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Court of Appeals Reverses Lower Court Decision in Favor of TriMed, Inc. Patent Infringement Case
2. Endu Receives Gold Medal for Outstanding Chinese Patented Invention Award
3. Closer Analysis Shows Consumer Groups Make Gains in Stem Cell Patent Challenges Against WARF; Appeal Still Planned Against Narrowed Claims
4. Consumer Groups Will Continue to Press Stem Cell Patent Challenge
5. IDC receives patent on dual energy imaging technology
6. Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
7. A device that measures optimum state of an organ prior to transplanting has been patented
8. CryoCath Provides Update on Patent Infringement Lawsuit
9. GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C
10. Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve in the U.S.
11. Carringtons DelSite Drug Delivery Technology Granted Patent From Eurasian Patent Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... ... April 30, 2016 , ... Orlando-based Maximized Living has selected Dr. Nick Wilson ... Rio. Under the care of Maximized Living doctors at the London Olympics in ... Maximized Living is sending the largest contingent of elite chiropractors to Rio to support ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... by the Accreditation Council for Graduate Medical Education (ACGME) that it has received ... is the first accreditation of three residency programs that Memorial is currently pursuing, ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Bernie Siegel, ... seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related to Death live on ... . Dr. Bernie Siegel, author of a plethora of essential books-to-read for ...
(Date:4/29/2016)... Southlake, Texas (PRWEB) , ... April 29, 2016 , ... ... and neck pain, is proud to announce one of their physicians has been invited ... Osteopathic Family Physicians (Texas ACOFP) Family Practice Review conference on April 30, 2016. ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. ... for the majority of skin cancer deaths. More than 10,000 people are expected to die ... diagnosis is 62, it is the one of the most commonly diagnosed cancers in young ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 2016 Oasmia Pharmaceutical AB ... a new generation of drugs within human and ... for Paclical/Apealea in the Phase III study that ... ovarian cancer. These preliminary results showed non-inferiority between ... carboplatin versus Taxol in combination with carboplatin. In ...
(Date:4/27/2016)... April 27, 2016 At the ... launch of a Phase 2 clinical study of its ... patients undergoing cochlear implantation (CI) surgery. This large, placebo-controlled, ... Germany and France ... ear at the time of surgery. "Despite advances in ...
(Date:4/26/2016)... 26, 2016 US demand for infection ... 4.9 percent annually to $27.6 billion in 2020.  ... to decrease rates of healthcare-associated infections (HAIs) will ... and services.  Although declining, the overall rate of ... levels set by the CDC.  Recent statistics indicate ...
Breaking Medicine Technology: